Cargando…

SOX14 hypermethylation as a tumour biomarker in cervical cancer

BACKGROUND: The association between SOX14 and cancer has been reported. The aim of this study was to identify and validate the potential value of SOX14 methylation in the early detection of cervical cancer. METHODS: First, we extracted the data for SOX14 methylation and expression within cervical ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jing, Cao, Huiling, Zhang, Wenfan, Fan, Yongjuan, Shi, Shujuan, Wang, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185922/ https://www.ncbi.nlm.nih.gov/pubmed/34098886 http://dx.doi.org/10.1186/s12885-021-08406-2

Ejemplares similares

The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer
por: Zhang, Wenfan, et al.
Publicado: (2022)

SOX1 and PAX1 Are Hypermethylated in Cervical Adenocarcinoma and Associated with Better Prognosis
por: Zhao, Zitong, et al.
Publicado: (2020)

Hypermethylation of SOX2 Promoter in Endometrial Carcinogenesis
por: Wong, Oscar Gee-Wan, et al.
Publicado: (2010)

Promoter Hypermethylation of Tumour Suppressor Genes as Potential Biomarkers in Colorectal Cancer
por: Ng, Jennifer Mun-Kar, et al.
Publicado: (2015)

DNA hypermethylated status and gene expression of PAX1/SOX1 in patients with colorectal carcinoma
por: Huang, Jin, et al.
Publicado: (2017)

Aberrant Hypermethylation of SALL3 with HPV Involvement Contributes to the Carcinogenesis of Cervical Cancer
por: Wei, Xing, et al.
Publicado: (2015)

Hypermethylated genes as biomarkers of breast cancer
por: Fackler, MJ, et al.
Publicado: (2009)

SCTR hypermethylation is a diagnostic biomarker in colorectal cancer
por: Li, DaPeng, et al.
Publicado: (2020)

SOX1 Promoter Hypermethylation as a Potential Biomarker for High-Grade Squamous Intraepithelial Neoplasia Lesion and Cervical Carcinoma: A Meta-Analysis With Trial Sequential Analysis
por: Huang, Jin, et al.
Publicado: (2020)

Nucleocytoplasmic shuttling of SOX14A and SOX14B transcription factors
por: She, Zhen-Yu, et al.
Publicado: (2017)

Alu hypomethylation and MGMT hypermethylation in serum as biomarkers of glioma
por: Gong, Mingjie, et al.
Publicado: (2017)

Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays
por: Aleman, A, et al.
Publicado: (2008)

Promoter hypermethylation analysis of host genes in cervical intraepithelial neoplasia and cervical cancers on histological cervical specimens
por: Shi, Liye, et al.
Publicado: (2023)

Hypermethylated PCDHGB7 as a Biomarker for Early Detection of Endometrial Cancer in Endometrial Brush Samples and Cervical Scrapings
por: Yuan, Jiangjing, et al.
Publicado: (2022)

Aberrant DNA hypermethylation-silenced SOX21-AS1 gene expression and its clinical importance in oral cancer
por: Yang, Cheng-Mei, et al.
Publicado: (2016)

Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer
por: De Faveri, L E, et al.
Publicado: (2013)

SOX2 promoter hypermethylation in non-smoking Taiwanese adults residing in air pollution areas
por: Tantoh, Disline Manli, et al.
Publicado: (2019)

Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer
por: Gu, Simeng, et al.
Publicado: (2019)

Silencing NKD2 by promoter region hypermethylation promotes gastric cancer invasion and metastasis by up-regulating SOX18 in human gastric cancer
por: Jia, Yan, et al.
Publicado: (2015)

Hypermethylation of DcR1 Gene-based Biomarker in Non-invasive Cancer Screening of Vietnamese Cervical Cancer Patients
por: TRUONG, Phuong Kim, et al.
Publicado: (2018)

Is APC hypermethylation a diagnostic biomarker for bladder cancer? A meta-analysis
por: Han, Wei, et al.
Publicado: (2018)

Hypermethylated CDO1 and ZNF454 in Cytological Specimens as Screening Biomarkers for Endometrial Cancer
por: Wang, Lei, et al.
Publicado: (2022)

Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer
por: Shaw, R J, et al.
Publicado: (2009)

Hypermethylation of APC2 Is a Predictive Epigenetic Biomarker for Chinese Colorectal Cancer
por: He, Yuan, et al.
Publicado: (2018)

Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
por: Juhlin, C. Christofer, et al.
Publicado: (2010)

CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2017)

Hypermethylated DNA, a circulating biomarker for colorectal cancer detection
por: Rasmussen, Simon Ladefoged, et al.
Publicado: (2017)

Saliva Gene Promoter Hypermethylation as a Biomarker in Oral Cancer
por: Rapado-González, Óscar, et al.
Publicado: (2021)

Hypermethylation of miR-145 promoter-mediated SOX9-CLDN8 pathway regulates intestinal mucosal barrier in Crohn's disease
por: Zhuang, Xiaojun, et al.
Publicado: (2022)

Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer
por: Kitkumthorn, Nakarin, et al.
Publicado: (2006)

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer
por: Yao, Tingting, et al.
Publicado: (2013)

Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene
por: Miller, Shyra J, et al.
Publicado: (2009)

Promoter Hypermethylation of the ATM Gene as a Novel Biomarker for Breast Cancer
por: Begam, Nasrin, et al.
Publicado: (2017)

SOX14 activates the p53 signaling pathway and induces apoptosis in a cervical carcinoma cell line
por: Stanisavljevic, Danijela, et al.
Publicado: (2017)

Hypermethylated 14-3-3-σ and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis
por: Zurita, Mercedes, et al.
Publicado: (2010)

Hypermethylation of N-Acetyltransferase 1 Is a Prognostic Biomarker in Colon Adenocarcinoma
por: Shi, Cheng, et al.
Publicado: (2019)

Detection of hypermethylated genes as markers for cervical screening in women living with HIV
por: Kremer, Wieke W, et al.
Publicado: (2018)

CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2017)

NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population
por: Chen, Xiaoying, et al.
Publicado: (2016)

Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer
por: Zhang, Jun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o4dv6uddjss2pt7k19vh6k6ber